Professor of Pediatrics and Neurology
United States of America
Dr. Kevin Flanigan is a Professor of Neurology and Pediatrics at the Ohio State University, and a Principal Investigator at the Center for Gene Therapy at Nationwide Children’s Hospital in Columbus, Ohio. He has extensive experience in the design and development of patient registries, and has served as the Director of the United Dystrophinopathy Project, an NIH-funded genotype/phenotype database and registry.
He is a longstanding advocate of transnational efforts in neuromuscular disease, and during a sabbatical at the Institute of Myology in Paris, he helped to develop the minimal data elements of the TREAT-NMD DMD database. He currently serves on the TREAT-NMD Global Database Oversight Committee; the Therapeutic Advisory Committee of TREAT-NMD; the Executive Board of the World Muscle Society; and on advisory committees to establish common data elements for neuromuscular studies for the NINDS. He has extensive experience in clinical trials, and has served on clinical trial advisory committees for PTC Therapeutics, Prosensa, GSK, and AVI. He has appeared before the FDA as part of the IND application process, and has experience in designing IND-enabling pre-clinical programs, including one currently funded by an NIH U01 award directed at gene therapy for MPSIIIB.